Searched for
ZAHABIYA KHORAKIWALA
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Mumbai’s Wockhardt Hospital facility back on feetZahabiya Khorakiwala, managing director of Wockhardt Hospitals, told ET the hospital is not ready to offer emergency care for other ailment...
- Sell Wockhardt, target Rs 705: Manas JaiswalSell Wockhardt Ltd. at a price target of Rs 705.0 and a stop loss at Rs 741 from entry point.
- Buy Wockhardt, target Rs 880: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 880.0 and a stop loss at Rs 800 from entry point.
- Buy Wockhardt, target Rs 840: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 840.0 and a stop loss at Rs 810 from entry point.
- Buy Wockhardt, target Rs 795: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 795.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 985: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 985.0 and a stop loss at Rs 940 from entry point.
- Buy Wockhardt, target Rs 850: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 850.0 and a stop loss at Rs 795 from entry point.
- Buy Wockhardt, target Rs 800: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 800.0 and a stop loss at Rs 775 from entry point.
- Buy Wockhardt, target Rs 820: Rajesh PalviyaBuy Wockhardt Ltd. at a price target of Rs 820.0 and a stop loss at Rs 710 from entry point.
- Buy Wockhardt, target Rs 775: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 775.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 825: Kunal BothraBuy Wockhardt at a price target of Rs 825.0 and a stop loss at Rs 725 from entry point.
- Buy Wockhardt, target Rs 770: Dr CK NarayanBuy Wockhardt at a price target of Rs 770 and a stop loss at Rs 745 from entry point.
- Buy Wockhardt, target Rs 780: Kunal BothraBuy Wockhardt at a price target of Rs 780 and a stop loss at Rs 700 from entry point.
- Wockhardt Q2 net loss at Rs 3.33 croreIn a separate filing, Wockhardt said its board has appointed Zahabiya Khorakiwala as additional director of the company.
- Style-check: Pearls it is for Wockhardt Hospitals MD Zahabiya KhorakiwalaKhorakiwala said that she finalises her look in 10 minutes.
- No plans of selling Wockhardt Pharma: Habil KhorakiwalaKhorakiwala also stressed that he has no plans of divesting in favour of any other sector, and plans to stick with healthcare.
- How Zahabiya Khorakiwala has made father Habil proudIn particular, there’s one memory that makes both smile: At age 15, Zahabiya was sent to Aiglon boarding school in Switzerland for two year...
- Wockhardt Hospitals aims at business from tier-II townsAs the group clambers out of a debt trap, Habib Khorakiwala’s daughter Zahabiya plans strategy to get hospital biz back on track.
Load More- Sell Wockhardt, target Rs 705: Manas Jaiswal
